Skip to content

Effect of Low-Power Laser Therapy on Pain and Functional Outcomes in Patients With Thoracic Outlet Syndrome

Effect of Low-Power Laser Therapy on Pain and Functional Outcomes in Patients With Thoracic Outlet Syndrome

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07535853
Acronym
LPLT-TOS
Enrollment
40
Registered
2026-04-17
Start date
2026-04-20
Completion date
2026-07-17
Last updated
2026-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracic Outlet Syndrome

Keywords

LPLT

Brief summary

The purpose of this study is to evaluate the effect of low-power laser therapy on pain intensity and functional outcomes in patients diagnosed with Thoracic Outlet Syndrome (TOS). Participants will be randomly assigned to either receive the active laser therapy combined with a physical therapy program or a control group. The study aims to determine if adding laser therapy provides better relief and improves daily physical functions compared to conventional treatment alone.

Interventions

DEVICELow level laser therapy

"Patients will receive low-level laser therapy using a Gallium-Aluminum-Arsenide (GaAlAs) laser diode. Wavelength: 850nm, Power: 100mW. It will be applied to specific trigger points in the neck and shoulder area for 5 minutes per session, 3 times per week for 4 weeks."

DEVICETherapeutic Ultrasound

"Pulsed therapeutic ultrasound applied to the symptomatic area. Frequency: 1 MHz, Intensity: 1.5 W/cm², Duty cycle: 20%. The treatment will be applied for 5-8 minutes per session."

A supervised physical therapy program focusing on stretching and strengthening exercises for the neck and shoulder girdle. This includes stretching of the scalene and pectoralis minor muscles, as well as strengthening of the middle and lower trapezius and serratus anterior. Each session lasts 30 minutes, twice per week for 8 weeks.

"The same laser device will be used as in the experimental group, but without delivering any active laser energy. The device will be applied to the same points for the same duration to ensure blinding of the participants."

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
30 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Age Inclusion Criteria: * Age between 35-50 years. * Clinically diagnosed with Thoracic Outlet Syndrome (TOS) by a physician based on standard diagnostic criteria. * Presence of neurogenic symptoms such as pain, paraesthesia, numbness, or -- * weakness in the upper extremity. * Symptoms lasting for at least 3 months.

Exclusion criteria

* History of cervical disc herniation or cervical radiculopathy. * Previous surgical intervention in the cervical or thoracic outlet region. * Severe cardiovascular or systemic diseases that may interfere with treatment. --Pacemakers or other implanted electronic devices. * Skin conditions or infections in the treatment area. * Receiving any other form of laser therapy or conflicting treatment during the study.

Design outcomes

Primary

MeasureTime frameDescription
Pressure Pain Threshold (PPT)Baseline and 2 months post-treatment.The minimum pressure at which a stimulus is perceived as painful, measured using a digital pressure algometer at specific trigger points. The device measures the pressure in kilograms per square centimeter (kg/cm²).

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 18, 2026